National survey of fibrinogen concentrate usage for post-partum hemorrhage in Japan: investigated by the Perinatology Committee, Japan Society of Obstetrics and Gynecology.

Published on Aug 1, 2015in Journal of Obstetrics and Gynaecology Research1.73
· DOI :10.1111/JOG.12708
Shintaro Makino14
Estimated H-index: 14
(Juntendo University),
Satoru Takeda32
Estimated H-index: 32
(Juntendo University)
+ 4 AuthorsHideaki Masuzaki46
Estimated H-index: 46
(Nagasaki University)
Sources
Abstract
Aim The aim of this study was to provide basic documents applicable to studying the usefulness of administering fibrinogen concentrate to patients with massive post-partum hemorrhage. We investigated the usage of fibrinogen concentrate at training institutions for specialist physicians of the Japan Society of Obstetrics and Gynecology. Material and Methods The subjects were women who required fibrinogen concentrate for hemostasis of post-partum hemorrhage during the period between April 2008 and March 2013. The underlying diseases, obstetric disseminated intravascular coagulation scores, blood loss, amount of blood transfusion, dose of fibrinogen concentrate administered, and plasma fibrinogen levels before and after the administration of fibrinogen concentrate were retrospectively investigated. Results Ninety-nine (98.0%) patients survived and two died after taking fibrinogen concentrate. Of the surviving 99 cases, the average amount of blood loss at the time of initial fibrinogen administration and total blood loss was 3559 ± 2103 mL and 4562 ± 3198 mL, respectively. The dose per administration was 3 g, and the plasma fibrinogen level before the initial administration of fibrinogen concentrate was 70.5 mg/dL, thereafter increasing to 187.0 mg/dL. The increase in the fibrinogen level was 32.9 mg/dL/g of fibrinogen concentrate. It was less than 150 mg/dL after the first administration of fibrinogen concentrate only in patients with amniotic fluid embolism and patients with atonic bleeding showed the smallest increase in fibrinogen per gram of fibrinogen concentrate. No adverse events, including thromboembolism, were reported. Conclusion The results indicated the increase in blood fibrinogen levels to, on occasion, be insufficient even with fibrinogen concentrate use; however, this survey may support the safety and usefulness of fibrinogen concentrate for PPH.
Download
📖 Papers frequently viewed together
References10
Newest
Obstetrical disseminated intravascular coagulation (DIC) is usually a very acute, serious complication of pregnancy. The obstetrical DIC score helps with making a prompt diagnosis and starting treatment early. This DIC score, in which higher scores are given for clinical parameters rather than for laboratory parameters, has three components: (i) the underlying diseases; (ii) the clinical symptoms; and (iii) the laboratory findings (coagulation tests). It is justifiably appropriate to initiate th...
Source
#1Mariko Kikuchi (Saitama Medical University)H-Index: 2
#2Atsuo Itakura (Saitama Medical University)H-Index: 27
Last. Osamu Ishihara (Saitama Medical University)H-Index: 30
view all 6 authors...
Aim The aim of this study was to assess the efficacy and safety of fibrinogen concentrate therapy for women with obstetric hemorrhage complicated by dilutional or consumptive coagulopathy by retrospectively reviewing the medical records of relevant patients from a single tertiary center. Material and Methods Eighteen cases of coagulopathy (8 dilutional, 10 consumptive) administered fibrinogen concentrate at our center over the past 5 years for treating hypofibrinogenemia were identified. Hemoglo...
Source
#1Niels Rahe-Meyer (MHH: Hannover Medical School)H-Index: 28
#2Alexander A. Hanke (MHH: Hannover Medical School)H-Index: 25
Last. Maximilian Pichlmaier (MHH: Hannover Medical School)H-Index: 17
view all 5 authors...
Objectives We assessed whether fibrinogen concentrate as targeted first-line hemostatic therapy was more effective than placebo or a standardized transfusion algorithm in controlling coagulopathic bleeding in patients undergoing major aortic surgery. Methods In this single-center, prospective, double-blind study, adults undergoing elective thoracic or thoracoabdominal aortic replacement surgery involving cardiopulmonary bypass were randomized to intraoperative fibrinogen concentrate (n = 29) or ...
Source
#1Anne-Sophie Ducloy-Bouthors (university of lille)H-Index: 10
#2É. Blondé-Zoonekynd (university of lille)H-Index: 1
Last. Sophie Susen (university of lille)H-Index: 34
view all 11 authors...
Resume L’hemorragie du post-partum est la premiere cause de mort maternelle en France et dans le monde. La prise en charge protocolee et chronometree de l’hemorragie obstetricale peut contribuer a reduire la morbi-mortalite liee a cette pathologie. La reanimation s’appuiera sur une organisation anticipee des soins garante de l’acces aux gestes d’hemostase, aux moyens de surveillance et aux produits sanguins. La transfusion est au cœur de ce dispositif.
Source
The diagnosis of disseminated intravascular coagulation (DIC) should encompass both clinical and laboratory information. The International Society for Thrombosis and Haemostasis (ISTH) DIC scoring system provides objective measurement of DIC. Where DIC is present the scoring system correlates with key clinical observations and outcomes. It is important to repeat the tests to monitor the dynamically changing scenario based on laboratory results and clinical observations. The cornerstone of the tr...
Source
#1Matthew Burtelow (Stanford University)H-Index: 2
#2Edward T. Riley (Stanford University)H-Index: 33
Last. Lawrence T. Goodnough (Stanford University)H-Index: 100
view all 6 authors...
Management of massive, life-threatening primary postpartum hemorrhage in the labor and delivery service is a challenge for the clinical team and hospital transfusion service. Because severe postpartum obstetrical hemorrhage is uncommon, its occurrence can result in emergent but variable and nonstandard requests for blood products. The implementation of a standardized massive transfusion protocol for the labor and delivery department at our institution after a maternal death caused by amniotic fl...
Source
Summary. Background: Postpartum hemorrhage (PPH) is a major source of maternal morbidity. Objectives: This study's objective was to determine whether changes in hemostasis markers during the course of PPH are predictive of its severity. Patients and methods: We enrolled 128 women with PPH requiring uterotonic prostaglandin E2 (sulprostone) infusion. Two groups were defined (severe and non-severe PPH) according to the outcome during the first 24 hours. According to our criteria, 50 of the 128 wom...
Source
Pregnancy, from implantation to parturition, presents unique and profound challenges to a women's hemostatic system. During pregnancy, potentially catastrophic bleeding can occur during implantation and endovascular trophoblast invasion of the maternal spiral arteries. The risk of hemorrhage reaches
Source
Source
#1Seppo Hiippala (HYKS: Helsinki University Central Hospital)H-Index: 5
#2G. MyllyläH-Index: 19
Last. Elina VahteraH-Index: 19
view all 3 authors...
The purpose of this study was to assess the change of platelet and fibrinogen concentrations and the change of activities of prothrombin and factors V and VII when major surgical blood loss was replaced with plasmapoor red cell concentrates (RCCs) and colloid plasma substitutes.Sixty patients were studied. The average blood loss was 65% +/- 41% of the calculated blood volume (CBV). Blood loss was monitored carefully and replaced without delay to ensure stable blood volume. Blood samples were obt...
Source
Cited By23
Newest
OBJECTIVE To assess the benefits and safety of early human fibrinogen concentrate in postpartum haemorrhage (PPH) management. DESIGN Multicentre, double-blind, randomized placebo-controlled trial. SETTING 30 French hospitals. POPULATION patients with persistent PPH after vaginal delivery requiring a switch from oxytocin to prostaglandins. METHODS Within 30 min after introduction of prostaglandins, patients received either 3 g fibrinogen concentrate or placebo. MAIN OUTCOME MEASURES Failure as co...
Source
#1Daigo OchiaiH-Index: 9
#2Yushi AbeH-Index: 5
Last. Ryuji TanosakiH-Index: 38
view all 11 authors...
Background and objectives: Massive postpartum hemorrhage (PPH) is the most common cause of maternal death worldwide. A massive transfusion protocol (MTP) may be used to provide significant benefits in the management of PPH; however, only a limited number of hospitals use MTP protocol to manage massive obstetric hemorrhages, especially in Japan. This study aimed to assess the clinical outcomes in patients in whom MTP was activated in our hospital. Materials and Methods: We retrospectively reviewe...
Source
#1Mamoru Morikawa (Hokkaido University)H-Index: 24
#2Shigetaka Matsunaga (Saitama Medical University)H-Index: 8
Last. Takao Kobayashi (Hamamatsu University)H-Index: 2
view all 10 authors...
Japanese obstetrical hemorrhage recommendations state that not only pregnant women with an obstetrical disseminated intravascular coagulation (DIC) score ≥ 8 points but also those with fibrinogen levels ≤ 1.5 g/L have a high risk of maternal death and warrant blood transfusion. Our aim was to demonstrate the potential of fibrinogen levels ≤ 1.5 g/L as predictors of a Japanese obstetrical DIC score of ≥ 8. We included 595 participants with blood loss ≥ 1000 mL during vaginal delivery or ≥ 2000 mL...
Source
#1Shintaro Makino (Juntendo University)H-Index: 14
Source
#1Satoru Takeda (Juntendo University)H-Index: 32
#2Yasuhisa Terao (Juntendo University)H-Index: 13
Arterial ligation and stepwise uterine devascularization were formerly used as hemostatic techniques to control massive hemorrhage during cesarean section without hysterectomy and to preserve the uterus. However, depending on the sites of arterial ligation, the hemostatic effect was often inadequate because of collateral circulation. Subsequently, insufficient blood flow and ischemia in the preserved uterus caused ovarian dysfunction and endometrial growth impairment, (e.g., hypomenorrhea, oligo...
Source
#1Jun TakedaH-Index: 8
#2Shintaro MakinoH-Index: 14
Last. Satoru TakedaH-Index: 32
view all 3 authors...
Source
#1Jun Takeda (Juntendo University)H-Index: 8
#2Satoru Takeda (Juntendo University)H-Index: 32
Placental abruption is a condition that should be carefully considered in perinatal management because it is associated with serious events in both the mother and neonate, such as intrauterine fetal death, cerebral palsy, obstetric critical bleeding, and uncontrollable bleeding. The concomitant presence of disseminated intravascular coagulation (DIC) more easily causes critical bleeding that may necessitate hysterectomy or multi-organ failure resulting in maternal death. Therefore, early managem...
Source
#2Engin Çelik (Istanbul University)H-Index: 4
Last. Hüsnü Görgen (Acıbadem University)H-Index: 8
view all 6 authors...
AbstractObjective: The diagnosis of disseminated intravascular coagulation (DIC) in obstetrics is complicated owing to physiological changes, particularly during late pregnancy and the postpartum period. Therefore, a pregnancy-modified DIC score that includes only three components of the International Society on Thrombosis and Hemostasis (ISTH) DIC score has been constructed. Our aim was to determine how many blood-transfused postpartum women actually had the diagnosis of overt DIC according to ...
Source
#1Manuel Muñoz (UMA: University of Málaga)H-Index: 56
#2Jakob StensballeH-Index: 34
Last. Jean-François Hardy (UdeM: Université de Montréal)H-Index: 31
view all 14 authors...
: Patient blood management (PBM) is the timely application of evidence-informed medical and surgical concepts designed to maintain haemoglobin concentration, optimise haemostasis, and minimise blood loss in an effort to improve patient outcomes. The aim of this consensus statement is to provide recommendations on the prevention and treatment of postpartum haemorrhage as part of PBM in obstetrics. A multidisciplinary panel of physicians with expertise in obstetrics, anaesthesia, haematology, and ...
Source
#1Shigetaka Matsunaga (Saitama Medical University)H-Index: 8
#2Yasushi Takai (Saitama Medical University)H-Index: 13
Last. Hiroyuki Seki (Saitama Medical University)H-Index: 20
view all 3 authors...
AIM: In cases of critical obstetric hemorrhage leading to extreme hypofibrinogenemia, fibrinogen is the marker that indicates the critical severity, and early fibrinogen supplementation centering on hemostatic resuscitation is a vital treatment to stabilize a catastrophic condition. In this review, we investigated the effect of fibrinogen level on hemostasis and what we can do to treat hypofibrinogenemia efficiently and improve patients' outcome. METHODS: We reviewed numerous articles related to...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.